![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.00 | 10.50 | 11.50 | 11.00 | 11.00 | 11.00 | 22,890 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0284 | -3.87 | 13.39M |
TIDMABDX
RNS Number : 1734R
Abingdon Health PLC
25 October 2023
Abingdon Health plc
("Abingdon Health" or the "Company")
Director Dealing
York, U.K. 25 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests announces that on the 24(th) October 2023, Dr Chris Hand, Non-Executive Chairman purchased ordinary shares of 0.025 pence each in the Company ("Ordinary Shares").
Further details are as follows:
Director No. Ordinary Aggregate Enlarged Enlarged Shares Purchased Purchase Price Holding Holding* (Pence per (No. Ordinary (Per cent. Ordinary Share) Shares) of Total Voting Rights) Dr Chris Hand 150,000 10.167 13,178,467 10.83%
*Excluding options over Ordinary Shares
The Notification of Dealing Form required in accordance with UK MAR is set out below.
Enquiries:
Abingdon Health plc www.abingdonhealth.com/investors/ Chris Yates, Chief Executive Officer Via Walbrook PR Chris Hand, Non-Executive Chairman Singer Capital Markets (Sole Broker Tel: +44 (0)20 7496 3000 and Nominated Adviser) Peter Steel, Alex Bond, Jalini Kalaravy Walbrook PR Limited Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com Paul McManus, Phillip Marriage, Mob: +44 (0)7980 541 893 / +44 (0)7867 Alice Woodings 984 082 +44 (0)7407 804 654
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Dr Chris Hand ------------------------------ -------------------------------------------- Reason for the notification 2 ---------------------------------------------------------------------------- a) Position/status Non-Executive Chairman ------------------------------ -------------------------------------------- b) Initial notification Initial notification /Amendment ------------------------------ -------------------------------------------- Details of the issuer, emission allowance market participant, 3 auction platform, auctioneer or auction monitor ---------------------------------------------------------------------------- a) Name Abingdon Health plc ------------------------------ -------------------------------------------- b) LEI 213800XFI4WV3FBILO20 ------------------------------ -------------------------------------------- Details of the transaction(s): section to be repeated 4 for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------------------- a) Description of the Ordinary Shares of 0.025 pence each financial instrument, type of instrument Identification code GB00BLF79J41 b) Nature of the transaction Purchase of Ordinary Shares ------------------------------ -------------------------------------------- c) Price(s) and volume(s) --------------------- ----------- Price(s) Volume(s) --------------------- ----------- 10 pence per share 100,000 10.5 pence per share 50,000 -------------------------------------------------------------- ----------- d) Aggregated information - Aggregated volume 150,000 - Price 10.167 pence per share e) Date of the transaction 24(th) October 2023 ------------------------------ -------------------------------------------- f) Place of the transaction London Stock Exchange, AIM ------------------------------ --------------------------------------------
About Abingdon Health plc
Abingdon Health is a leading lateral flow contract research ("CRO") and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."
The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes.
Abingdon Health's Abingdon Simply Test (TM) range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test (TM) ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York, England.
For more information visit: www.abingdonhealth.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHKZLFLXBLFFBB
(END) Dow Jones Newswires
October 25, 2023 02:00 ET (06:00 GMT)
1 Year Abingdon Health Chart |
1 Month Abingdon Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions